주요서비스 바로가기
본문 바로가기
매체정보 바로가기
로그인 바로가기
기사검색 바로가기
전체서비스 바로가기
Updated : Saturday, Aprill 27, 2024, 14:40
Home
Login
Sign in
한국어
National
Foreign Affairs
Central & Regional Affairs
Social Issues
Economics
Macro-Economics
Trade
Foreign Exchanges
Industries
ICT
Automobiles
Heavy & Chemical
Defence
Entertainment
Energy
Construction
Healthcare & Bio
Consumer
Services
Stock Market
Company & Stock Tracking
Market Trend & Outlook
Finance
Capital Market
Crypto
Banking
Insurances
Startups
Science/Tech
Science
New Tech
Blockchain
ESG
Environment
Social
Governance
Event
Exhibitions
Conferences
People
K-Culture
Cinema/Drama
K-pop
Food
Lifestyle
Arts/Culture
Opinion
Editorials
Contributions
Who's Who
기사검색
검색
All articles
List
Subject Type
Summary Type
Photo Type
3 Celltrion Drugs Win Tenders by Public Organizations in Peru
이미지기사
Healthcare & Bio
Michael Herh
02.16 13:59
Celltrion Healthcare’s Vegzelma Listed as Preferred Medicine in US Prescription Directories
이미지기사
Healthcare & Bio
Jung Min-hee
2023.12.13 15:52
Samsung Biologics Ranks 2nd in Newsweek’s Most Trusted Healthcare Companies Worldwide
이미지기사
Healthcare & Bio
Jasmine Choi
2023.09.08 18:27
Celltrion Obtains Sales Approval in Australia for Avastin Biosimilar 'Vegzelma'
이미지기사
Healthcare & Bio
Jasmine Choi
2023.09.04 22:15
Celltrion Healthcare: Direct Sales to Begin in US
이미지기사
Finance
Park Pyeong-kuk
2022.11.14 13:12
Celltrion: 1Q22 Review: Earnings to Regain Momentum in 2H
이미지기사
Finance
Kim Tae-hee
2022.05.16 09:59
Celltrion: 4Q21 Review: Revenue Hits All-time Quarterly High
이미지기사
Finance
Kim Tae-hee
2022.02.17 10:57
Bio Industry: 2021 ASCO Review: Oscotec and MedPacto
Finance
Park Pyeong-kuk
2021.06.08 15:02
Pharmaceutical/bio: US Biosimilar Prescription Data for October
Finance
Lee Dong-geun & Won Jae-hee
2020.11.27 11:29
Celltrion: With New Drug Development, Potential to Veer Away From Biosimilars
이미지기사
Finance
Hong Ka-hye
2020.10.26 18:59
Samsung Biologics: Once Again, Earnings Surprise
Finance
William Ku
2020.04.21 18:17
Samsung BioLogics: Surge in Peer Lonza’s Share Price Warrants
Finance
William Ku
2020.02.13 16:37
Korean Drugs Account for Half of Global Top Eight Biopharmaceuticals
이미지기사
Industries
Choi Moon-hee
2019.01.16 13:38
Samsung Bioepis, Celltrion Competing over Development of Biosimilar to Avastin
이미지기사
Industries
Choi Moon-hee
2018.10.12 11:20
Korean Biosimilars Suffering from Global Pharmaceuticals’ Patents
이미지기사
Industries
Choi Mun-hee
2017.09.21 02:15
Korean Biosimilar Clinical Trials Approved More Than Multinational Pharma Firms’
이미지기사
Industries
Choi Mun-hee
2017.04.13 01:45
US FDA Accepted Samsung Bioepis’ BLA for SB2 Infliximab Biosimilar
이미지기사
Industries
marie
2016.05.24 06:30
Celltrion to Challenge Global Market Continuously by Developing New Biosimilars
이미지기사
Industries
marie
2016.04.05 06:30
Samsung Bioepis Enjoying Industry’s Broadest Biosimilar Pipelines
이미지기사
ESG
marie
2016.03.28 02:45
Samsung Achieves Unprecedented Results in Biosimilars Sector After 3 Years
이미지기사
Science/Tech
Jung Min-hee
2015.07.07 03:45
처음
1
끝
위로
모바일버전
All articles
National
전체
Foreign Affairs
Central & Regional Affairs
Social Issues
Economics
전체
Macro-Economics
Trade
Foreign Exchanges
Industries
전체
ICT
Automobiles
Heavy & Chemical
Defence
Entertainment
Energy
Construction
Healthcare & Bio
Consumer
Services
Stock Market
전체
Company & Stock Tracking
Market Trend & Outlook
Finance
전체
Capital Market
Crypto
Banking
Insurances
Startups
Science/Tech
전체
Science
New Tech
Blockchain
ESG
전체
Environment
Social
Governance
Event
전체
Exhibitions
Conferences
People
K-Culture
전체
Cinema/Drama
K-pop
Food
Lifestyle
Arts/Culture
Opinion
전체
Editorials
Contributions
Who's Who
전체메뉴닫기